Filters

SPANXN3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

SPANXN3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) size: 1.0 µg DNA 600

Supplier ABM LENTIVECTORS
Price 600
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetSPANXN3 Lentiviral Vector (CMV) (pLenti-GIII-CMV)
Short nameSPANXN3 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus), SPANXN3 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 33176
Gene SPANXN3
Long gene name SPANX family member N3
Synonyms gene name SPANX family, member N3
Synonyms SPANX-N3 CT11, 8
Synonyms name cancer/testis antigen family 11, member 8
Locus Xq27, 3
Discovery year 2006-11-13
Entrez gene record 139067
Pubmed identfication 14973187 17012309
RefSeq identity NM_001009609
Havana BLAST/BLAT OTTHUMG00000022582

Similar products

Subscribe to our Newsletter